218 related articles for article (PubMed ID: 16436809)
1. Integrated PET/CT: current applications and future directions.
von Schulthess GK; Steinert HC; Hany TF
Radiology; 2006 Feb; 238(2):405-22. PubMed ID: 16436809
[TBL] [Abstract][Full Text] [Related]
2. Imaging and PET-PET/CT imaging.
Von Schulthess GK; Hany TF
J Radiol; 2008 Mar; 89(3 Pt 2):438-47; quiz 448. PubMed ID: 18408643
[TBL] [Abstract][Full Text] [Related]
3. PET and PET/CT in pediatric oncology.
Jadvar H; Connolly LP; Fahey FH; Shulkin BL
Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
[TBL] [Abstract][Full Text] [Related]
4. PET/CT in diagnostic oncology.
Messa C; Bettinardi V; Picchio M; Pelosi E; Landoni C; Gianolli L; Gilardi MC; Fazio F
Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):66-75. PubMed ID: 15243404
[TBL] [Abstract][Full Text] [Related]
5. Integrated PET/CT and cancer imaging.
De Wever W; Coolen J; Verschakelen JA
JBR-BTR; 2009; 92(1):13-9. PubMed ID: 19358480
[TBL] [Abstract][Full Text] [Related]
6. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
7. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006.
Czernin J; Allen-Auerbach M; Schelbert HR
J Nucl Med; 2007 Jan; 48 Suppl 1():78S-88S. PubMed ID: 17204723
[TBL] [Abstract][Full Text] [Related]
8. PET/CT: form and function.
Blodgett TM; Meltzer CC; Townsend DW
Radiology; 2007 Feb; 242(2):360-85. PubMed ID: 17255408
[TBL] [Abstract][Full Text] [Related]
9. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
10. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
11. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
12. Evolving role of 18F-FDG-PET/CT for the body tumor and metastases in pediatrics.
Chen Z; Li X; Li F; Ouyang Q; Yu T
Eur J Radiol; 2010 Sep; 75(3):329-35. PubMed ID: 20576385
[TBL] [Abstract][Full Text] [Related]
13. Value of iterative reconstruction, attenuation correction, and image fusion in the interpretation of FDG PET images with an integrated dual-head coincidence camera and X-ray-based attenuation maps.
Delbeke D; Martin WH; Patton JA; Sandler MP
Radiology; 2001 Jan; 218(1):163-71. PubMed ID: 11152796
[TBL] [Abstract][Full Text] [Related]
14. Role of fluorodeoxyglucose-PET versus fluorodeoxyglucose-PET/computed tomography in detection of unknown primary tumor: a meta-analysis of the literature.
Dong MJ; Zhao K; Lin XT; Zhao J; Ruan LX; Liu ZF
Nucl Med Commun; 2008 Sep; 29(9):791-802. PubMed ID: 18677207
[TBL] [Abstract][Full Text] [Related]
15. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; von Schulthess GK; Steinert HC
N Engl J Med; 2003 Jun; 348(25):2500-7. PubMed ID: 12815135
[TBL] [Abstract][Full Text] [Related]
16. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
17. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K
Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
[TBL] [Abstract][Full Text] [Related]
18. PET-CT in oncology: making the most of CT.
Miles KA
Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S87-93. PubMed ID: 18852084
[TBL] [Abstract][Full Text] [Related]
19. Clinical applications of PET and PET/CT in pediatric malignancies.
Kumar R; Shandal V; Shamim SA; Halanaik D; Malhotra A
Expert Rev Anticancer Ther; 2010 May; 10(5):755-68. PubMed ID: 20470007
[TBL] [Abstract][Full Text] [Related]
20. Integrated positron emission tomography/computed tomography fusion imaging: an emerging gold standard in lung cancer.
Joshi SC; Pant I; Hamzah F; Kumar G; Shukla AN
Indian J Cancer; 2008; 45(4):137-41. PubMed ID: 19112200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]